ArticleeLife2019
Open access · goldAbstract read
In one paragraph
Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
68 citing papers in PubMed, 1 synthesis or guideline pooled it, 133 citations in OpenAlex.
- Effects of Probiotics on Preterm Infant Gut Microbiota Across Populations: A Systematic Review and Meta-Analysis.Advances in nutrition (Bethesda, Md.) · 2024Pooled it
- Impact of Enterococcus faecium 129 BIO 3B-R on Helicobacter pylori eradication therapy side effects in adult patients: a randomized, double-blind, placebo-controlled study.Scientific reports · 2025Trial
- Pilot study evaluating tolerability and changes in fecal microbiota associated with novel probiotic administration to dogs with diarrhea.Frontiers in veterinary science · 2025Trial
- Toward a Dual-Axis Model of Microbiome Modulation in Cancer Immunotherapy: Pathobiont Elimination and Functional Ecosystem Restoration.Cellular and molecular bioengineering · 2026Article
- Genetic and pharmacological inactivation of peptidoglycan remodeling increases antibiotic susceptibility of vancomycin-resistant Enterococcus faecium.Nature communications · 2026Article
- Identification of Campylobactercoli as a key pathogen in Jinhua piglet diarrhea and its the probiotic control by Enterococcus faecium.BMC microbiology · 2026Article
- Harnessing the Microbiome in Cancer Immunotherapy: Regulation, Prediction, and Therapeutic Targeting.Annual review of immunology · 2026Review
- Enterococcus faecalis KU-EF-004 enhances efficacy of anti-CTLA-4 immunotherapy for colorectal cancer via dendritic cell activation and gut microbiota modulation.BMC immunology · 2026Article
- Genetic and pharmacological inactivation of peptidoglycan remodeling increases antibiotic susceptibility of vancomycin-resistantbioRxiv : the preprint server for biology · 2026Article
- Article
- The association between neonatal respiratory distress syndrome and gut microbiota dysbiosis: evidence from metagenomics.Frontiers in microbiology · 2026Article
- Taming Superbugs: Current Progress and Challenges in Combating ESKAPE Pathogens.Pathogens (Basel, Switzerland) · 2025Review
- Article
- Transcriptome-guided discovery of novel plant-associated genes in a rhizosphere Pseudomonas.Microbiome · 2025Article
- Article
- Effects ofVeterinary sciences · 2025Article
- The Role of the Microbiome in the Resolution of Infection-Induced Inflammation.ACS infectious diseases · 2025Review
- Optimistic effects of dual nano-encapsulated probiotics on breeders laying performance, intestinal barrier functions, immunity and resistance against Salmonella Typhimurium challenge.Scientific reports · 2025Article
- Microbiota mechanisms in cancer progression and therapy.Cell chemical biology · 2025Review
- Ultrasound-Stimulated Microbubble Cavitation Combined With Anti-PD-L1 Blockade Inhibits the Progression of MC38 Tumors and Alters the Composition of Gut Microbiota in Mice.International journal of microbiology · 2025Article
8 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 3 institutions in 2 countries.
Byungchul KimLaboratory of Chemical Biology and Microbial Pathogenesis, The Rockefeller University, New York, United States.ORCID 0000-0002-0207-7357
Yen-Chih WangLaboratory of Chemical Biology and Microbial Pathogenesis, The Rockefeller University, New York, United States.
Charles W HespenLaboratory of Chemical Biology and Microbial Pathogenesis, The Rockefeller University, New York, United States.ORCID 0000-0001-5466-0280
Juliel EspinosaLaboratory of Chemical Biology and Microbial Pathogenesis, The Rockefeller University, New York, United States.ORCID 0000-0003-2104-5331
Jeanne SaljeCentre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Kavita J RanganLaboratory of Chemical Biology and Microbial Pathogenesis, The Rockefeller University, New York, United States.
Deena A OrenStructural Biology Resource Center, The Rockefeller University, New York, United States.
Jin Young KangLaboratory of Molecular Biophysics, The Rockefeller University, New York, United States.
Virginia A PedicordLaboratory of Chemical Biology and Microbial Pathogenesis, The Rockefeller University, New York, United States.
Howard C HangLaboratory of Chemical Biology and Microbial Pathogenesis, The Rockefeller University, New York, United States.ORCID 0000-0003-4053-5547
Rockefeller University · USUniversity of Cambridge · GBUniversity of Oxford · GB
Funding
Immunity and Infectious DiseaseT32AI070084 · NIAID · ROCKEFELLER UNIVERSITY · PI Michel C Nussenzweig · 2008 to 2026
$3.3MElucidation of Commensal Bacteria Mechanisms Required for Host ProtectionR01GM103593 · NIGMS · ROCKEFELLER UNIVERSITY · PI HANG, HOWARD C · 2013 to 2020
$2.8MAcquisition of a DeltaVision OMX SR 3D SIM system for super-resolution imagingS10RR031855 · NCRR · ROCKEFELLER UNIVERSITY · PI NORTH, ALISON JANE · 2011 to 2011
$600kDistal gut microbiome targets of host anti-proteolytic proteins during colitisR21AI156674 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI HANG, HOWARD C · 2021 to 2022
$488kMechanistic analysis and engineering probiotic bacteria with SagAF32AT010087 · NCCIH · ROCKEFELLER UNIVERSITY · PI HESPEN, CHARLES W · 2019 to 2021
$200kCrystallization Robot for the Structural Biology Resource Center at RockefellerS10RR027037 · NCRR · ROCKEFELLER UNIVERSITY · PI OREN, DEENA ABELLS · 2010 to 2010
$147kCancer Research Institute Postdoctoral fellowshipNCCIH NIH HHS F32 AT010087NCCIH NIH HHS F32AT010087NCRR NIH HHS S10 RR027037NCRR NIH HHS S10 RR031855NIAID NIH HHS R21 AI156674NIAID NIH HHS T32 AI070084NIGMS NIH HHS R01 GM103593NIGMS NIH HHS R01GM103593
Abstract
We discovered that
Indexed as
Antigens, BacterialCrystallography, X-RayEnterococcus faeciumHEK293 CellsHumansN-Acetylmuramoyl-L-alanine AmidaseNod2 Signaling Adaptor ProteinPeptidoglycanProtein ConformationAntigens, BacterialN-Acetylmuramoyl-L-alanine AmidaseNOD2 protein, humanNod2 Signaling Adaptor ProteinPeptidoglycanbiochemistrychemical biologycommensal bacteriaEnterococcusintestinal barriermicrobiotaNOD2peptidoglycan
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.